Oral hydration and alkalinization is noninferior to intravenous therapy for prevention of contrast-induced nephropathy in patients with chronic kidney disease

Journal of Interventional Cardiology

Volumn 23, Issue 5, 2010, Pages 460-466

  Cho, Roy ^a   Javed, Nosheen ^a   Traub, Darren ^a   Kodali, Sobhan ^a   Atem, Folefac ^a   Srinivasan, Venkatraman ^a  

^a WESTERN PENNSYLVANIA HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BICARBONATE; CLOPIDOGREL; CONTRAST MEDIUM; CREATININE; ISOVERSOL; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

AGED; ALKALINIZATION; ARTICLE; CHRONIC KIDNEY DISEASE; CINEANGIOCARDIOGRAPHY; CLINICAL TRIAL; CONTRAST INDUCED NEPHROPATHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; FEMALE; HUMAN; HYDRATION; INTRAVENOUS ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ACETYLCYSTEINE; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; BICARBONATES; BUFFERS; CONFIDENCE INTERVALS; CONTRAST MEDIA; CROSS-OVER STUDIES; FEMALE; FREE RADICAL SCAVENGERS; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY FAILURE, CHRONIC; LENGTH OF STAY; MALE;

EID: 77957744103     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2010.00585.x     Document Type: Article

References (22)

1. Gupta R, Birnbaum Y, Uretsky BF. The renal patient with coronary artery disease. Current concepts and dilemmas. J Am Coll 2004 44 : 1343 1353.
2. McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: Incidence, risk factors, and relationship to mortality. A J Med 1997 103 : 368 375.
3. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996 275 : 1489 1494.
4. Rihal CS, Textor SC, Grill DE, et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 2002 105 : 2259 2264.
5. McCullough PA, Sandberg KR. Epidemiology of contrast-induced nephropathy. Rev Cardiovas Med 2003 4S5 : S3 S9.
6. Bartholomew BA, Harhai KJ, et al. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. Am J Cardiol 2004 93 : 1515 1519.
7. Stone G, McCullogh P, Tumlin J, et al. A prospective randomized placebo-controlled trial evaluating fenoldopam mesylate for the prevention of contrast nephropathy. Am Heart J 2002 143 : 894 903.
8. Gare M, Haviv Y, Ben-Yehuda A, et al. The renal effects of low-dose dopamine in high-risk patients undergoing coronary angiography. J Am Coll Cardiol 1999 34 : 1682 1688.
9. Merten GJ, Burgess WP, et al. Prevention of contrast-induced nephropathy with sodium bicarbonate. JAMA 2004 19 : 2328 2334.
10. D'Agostino RB, Massaro JM, Sullivan LM. Non-inferiority trials: Design concept and issues - the encounters of academic consultants in statistics. Stat Med 2003 22 (2 169 186.
11. Durrleman S, Simon R. Planning and monitoring of equivalence studies. Biometrics 1990 46 : 329 336.
12. Mandallaz D, Mau J. Comparison of different methods in decision-making in bio-equivalence assessment. Biometrics 1981 37 : 1037 1040.
13. Rocke DM. On testing for bioequivalence. Biometrics 1984 40 : 225 230.
14. Lasagna L. Efficacy and generic drugs [letter]. Lancet 1987 2 : 218 219.
15. Weinrauch LA, Healy RV, Leland OS Jr., et al. Coronary angiography and acute renal failure in diabetic azotemic nephropathy. Ann Intern Med 1977 86 : 56 59.
16. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: A prospective controlled study. N Engl J Med 1989 320 : 143 149.
17. Best PJ, Lennon R, Ting HH, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous interventions. J Am Coll Cardiol 2002 39 : 1113 1119.
18. Bader BD, Berger ED, Heede MB, et al. What is the best hydration regimen to prevent contrast media-induced nephrotoxicity. Clin Nephrol 2004 62 : 1 7.
19. Taylor AJ, Hotchkiss D, Morse RM, et al. PREPARED: Preparation for angiography in renal dysfunction: A randomized trial of inpatient vs outpatient hydration protocols for cardiac catheterization in mild-to-moderate renal dysfunction. Am Coll Chest Physicians 1998 114 : 1570 1574.
20. Trivedi HS, Moore H, Nasr S, et al. A randomized prospective trial to assess the role of saline hydration on the develoment of contrast nephrotoxicity. Nephron Clin Pract 2003 93 : C29 C34.
21. Baliga R, Ueda N, Walker PD, et al. Oxidant mechanisms in toxic acute renal failure. Am J Kidney Dis 1997 29 : 465 477.
22. Pannu N, Wiebe N, Tonelli M. Prophylaxis strategies for contrast-induced nephropathy. JAMA 2006 295 (23 2765 2779.